These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 27672051

  • 21. Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
    Kawamoto T, Shoda J, Irimura T, Miyahara N, Furukawa M, Ueda T, Asano T, Kano M, Koike N, Fukao K, Tanaka N, Todoroki T.
    Clin Cancer Res; 2001 May; 7(5):1333-42. PubMed ID: 11350903
    [Abstract] [Full Text] [Related]

  • 22. Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence.
    Hamada T, Matsukita S, Goto M, Kitajima S, Batra SK, Irimura T, Sueyoshi K, Sugihara K, Yonezawa S.
    J Clin Pathol; 2004 Aug; 57(8):813-21. PubMed ID: 15280401
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas.
    Manne U, Weiss HL, Grizzle WE.
    Clin Cancer Res; 2000 Oct; 6(10):4017-25. PubMed ID: 11051251
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma.
    Baldus SE, Mönig SP, Hanisch FG, Zirbes TK, Flucke U, Oelert S, Zilkens G, Madejczik B, Thiele J, Schneider PM, Hölscher AH, Dienes HP.
    Histopathology; 2002 May; 40(5):440-9. PubMed ID: 12010364
    [Abstract] [Full Text] [Related]

  • 29. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
    Liu FF, Shen DH, Wang HL, Ma YT, Yuan F, Liu J, Chen L, Song QJ, Zhang YY.
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb 08; 48(2):92-97. PubMed ID: 30695858
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Combined status of MUC1 mucin and surfactant apoprotein A expression can predict the outcome of patients with small-size lung adenocarcinoma.
    Tsutsumida H, Goto M, Kitajima S, Kubota I, Hirotsu Y, Yonezawa S.
    Histopathology; 2004 Feb 08; 44(2):147-55. PubMed ID: 14764058
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in ALK-positive lung cancer: Comparison with EGFR-mutated lung cancer.
    Lee HK, Kwon MJ, Seo J, Kim JW, Hong M, Park HR, Min SK, Choe JY, Ra YJ, Jang SH, Hwang YI, Kim HY, Min KW.
    Pathol Res Pract; 2019 Mar 08; 215(3):459-465. PubMed ID: 30580903
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.
    Xiong L, Yang Z, Yang L, Liu J, Miao X.
    J Surg Oncol; 2012 Jan 08; 105(1):97-103. PubMed ID: 21815153
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.